STING induces type 1 IFN and CD8+ T-cell-mediated anti-tumor immunity [61], and enhances the production of immunosuppressive cytokines and impairs the infiltration of regulatory T-cells [62]. The gene discussed is CD8A; the disease is neoplasm.